Abstract:1551 Defining molecular similarities and differences between genetically engineered mouse models of mammary cancer and human breast cancer is critical to the further understanding of molecular mechanisms of oncogenesis and identifying models most relevant to human disease. One goal of this study was to use expression profiling in an attempt to determine whether several important, oncogenic pathway specific mouse models of mammary cancer could be classified according to the basal - luminal distinctions identified for human breast cancer. We demonstrate that all of the models studied in which p53 is mutated or functionally impaired and a BRCA1 mutant model cluster with human tumors in the basal-type category. All models in which the myc, ras, her2/neu and Polyoma middle T-antigen are driven by the MMTV promoter share molecular characteristics that cluster them with human luminal-type breast tumors. Interestingly, these models have been shown to lack ER-alpha expression (which is strongly associated with lack of GATA-3 expression in human breast cancers), but high expression of transcription factor GATA-3 is observed in our data for these models. A third group of mouse tumors include ER+ tumors arising from the p53fp/fp;Wap- cre model, which cluster with ER+ human tumors representing the luminal type A group. This new classification of GEM models provides a rational approach for further investigating the cellular origins of the different tumor classes and the appropriate use of the models in relation to the human tumor subclasses, especially pre-clinical testing. A second objective of this study was to determine whether mouse and human breast cancers share gene signatures based upon the status of ER expression. We have performed the first supervised comparison of gene expression profiles from mouse ER+ and ER- mammary tumors (generated by the mammary-specific conditional knock-out mutation of the p53 gene) with that of ER+ and ER- human breast tumors. Direct integration of gene expression levels from mouse tumors with that from human tumors (based upon ER expression) resulted in the most accurate classifier for ER status in human breast cancer, demonstrating the important added value of mouse data generated in a well-defined genetic background. The mouse-human ER classifier represents a set of genes co-expressed between mouse and human and can be placed into evolutionarily conserved networks based upon estrogen signaling. This approach reveals functionally conserved genes and networks across species important for cancer biology and identifying potential new therapeutic targets.

Integrated Mirna and Mrna Expression Profiling of Mouse Mammary Tumor Models Identifies Mirna Signatures Associated with Mammary Tumor Lineage

Expression Profile of Micrornas in C-Myc Induced Mouse Mammary Tumors

Genome-wide Screen for Aberrantly Expressed Mirnas Reveals Mirna Profile Signature in Breast Cancer

The Research Progress of the Interactions Between Mirna and Wnt/beta-catenin Signaling Pathway in Breast Cancer of Human and Mice .

Global Expression Profiling and Pathway Analysis of Mouse Mammary Tumor Reveals Strain and Stage Specific Dysregulated Pathways in Breast Cancer Progression.

Conserved Genetic Networks Define Er-Alpha Status And Luminal And Basal Phenotypes In Mouse And Human Mammary Cancer: Added Value From The Mouse

Model-Based Integration Analysis Revealed Presence of Novel Prognostic Mirna Targets and Important Cancer Driver Genes in Triple-Negative Breast Cancers.

Identification of Key Micrornas Involved in Tumorigenesis and Prognostic Micrornas in Breast Cancer

Integrated Analysis of Mouse and Human Gastric Neoplasms Identifies Conserved Microrna Networks in Gastric Carcinogenesis.

Microrna Expression Profiling Of Lactating Mammary Gland In Divergent Phenotype Swine Breeds

miRNA expression profiling of 51 human breast cancer cell lines reveals subtype and driver mutation-specific miRNAs

Human Mammary Microenvironment Better Regulates the Biology of Human Breast Cancer in Humanized Mouse Model

Mir-200 Enhances Mouse Breast Cancer Cell Colonization to Form Distant Metastases

MicroRNA expression analysis of mammospheres cultured from human breast cancers

MicroRNA Gene Expression Deregulation in Human Breast Cancer

Crucial Micrornas and Genes of Human Primary Breast Cancer Explored by Microrna-Mrna Integrated Analysis

A microRNA expression signature characterizing the properties of tumor-initiating cells for breast cancer.

Transposon Insertional Mutagenesis In Mice Identifies Human Breast Cancer Susceptibility Genes And Signatures For Stratification

Regulatory Network Reconstruction of Five Essential Micrornas for Survival Analysis in Breast Cancer by Integrating Mirna and Mrna Expression Datasets

MicroRNA93 Regulates Proliferation and Differentiation of Normal and Malignant Breast Stem Cells

Tumor-promoting Properties of Mir-8084 in Breast Cancer Through Enhancing Proliferation, Suppressing Apoptosis and Inducing Epithelial–mesenchymal Transition